NUCLEIX

EUIPO EUIPO 2023 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark NUCLEIX was filed as Figurative mark on 03/13/2023 at the European Union Intellectual Property Office.
It was registered as a trademark on 01/06/2024. The current status of the mark is "Trademark registered".

Logodesign (Wiener Klassifikation)

#Punctuation marks, brackets, quotation marks #Letters or numerals representing a figurative element

Trademark Details Last update: February 9, 2024

Trademark form Figurative mark
File reference 018847642
Application date March 13, 2023
Publication date September 26, 2023
Entry date January 6, 2024
Expiration date March 13, 2033

Trademark owner

Pekeris 3
7670203 Revohot
IL

Trademark representatives

Harcourt Centre, Block 4 Harcourt Road D02 HW77 Dublin IE

goods and services

1 Biochemical reagents for non-medical purposes; diagnostic preparations and reagents for scientific or research use; chemical and diagnostic preparations for clinical laboratory research or medical laboratory research use
5 Diagnostic test kits for medical and clinical use comprised of reagents for use in identifying and measuring changes associated with cancer, precancerous conditions or chronic obstructive pulmonary disease (COPD) or autoimmune disease or neurological disease; medical diagnostic assay kits comprised of reagents for use in identifying and measuring changes associated with cancer, precancerous conditions or chronic obstructive pulmonary disease (COPD) or autoimmune disease or neurological disease; medical diagnostic kits comprised of medical diagnostic reagents and assays for use in the field of cancer detection or detection of chronic obstructive pulmonary disease (COPD) or autoimmune disease or neurological disease; diagnostic reagents for medical purposes
10 Apparatus for medical diagnostic testing in the field of cancer or chronic obstructive pulmonary disease (COPD) or autoimmune disease or neurological disease
42 Pharmaceutical research and development; consulting services in the fields of biotechnology and pharmaceutical research and development; custom design and development of chemical reagents and biochemical assays
44 Consulting services in the field of health; consulting services in the field of diagnostic medical testing; medical analysis for the diagnosis of cancer and chronic obstructive pulmonary disease (COPD) or autoimmune disease or neurological disease and prognosis of expected progression of the diseases; medical testing for diagnostic or treatment purposes in the fields of the detection and treatment of cancer and chronic obstructive pulmonary disease (COPD) or autoimmune disease or neurological disease; providing cancer screening services; providing screening services for chronic obstructive pulmonary disease (COPD) or autoimmune disease or neurological disease; providing a website featuring information in the fields of the diagnosis and treatment of cancer and chronic obstructive pulmonary disease (COPD) or autoimmune disease or neurological disease

Trademark history

Date Document number Area Entry
March 17, 2023 Transfer / Change of address, Registered

ID: 11018847642